Jessica Meng
Jessica serves as Better's Chief Commercial Officer. She has a 20+ year track record in healthcare and extensive product launch leadership. In her most recent role as Chief Commercial Officer of DELFI Diagnostics, Jessica created and drove a nontraditional go-to-market strategy to gain early adoption of a revolutionary blood screening test for cancer, well ahead of guideline inclusion and broad reimbursement. She led the Women's Health Division of Myovant Sciences as General Manager and Vice President of Sales & Marketing, where she played a key role in the formation of the partnership with Pfizer. Prior to Myovant, Jessica was Vice President of Marketing for Veracyte, launching multiple genomic diagnostic products in oncology and pulmonology and helping to grow the commercial organization's headcount from 50 to 200. Jessica spent 10+ years in commercial leadership roles of increasing responsibilities at Genentech, most notably leading the marketing of Genentech's blockbuster oncology product, Avastin, to the height of its commercial success in gastrointestinal and gynecological cancers as well as glioblastoma. Jessica holds an MBA from the Wharton School of Business and Undergraduate degrees in Finance and International Relations from University of Pennsylvania.